483
Soleva Pharma LlcSoleva Pharma Llc – FDA 483, Mar 4, 2025
Record Details
An FDA inspection of Soleva Pharma Llc, a specification developer in Robbinsville, NJ, revealed significant deficiencies across multiple areas. The firm failed to adequately establish design verification procedures for its MuGard® product's extended shelf life, lacked proper complaint handling for four patient deaths, and did not label its medical device with the required unique device identifier. These observations indicate serious non-compliance with medical device regulations.
- Person
View Company Profile
ID · 189b2001-ccbe-4b7d-889e-50c26d3d1634
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.